2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …

K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

European heart rhythm association (EHRA)/heart rhythm society (HRS)/Asia pacific heart rhythm society (APHRS)/latin American heart rhythm society (LAHRS) expert …

AAM Wilde, C Semsarian, MF Márquez, AS Shamloo… - Europace, 2022 - academic.oup.com
Purpose Genetic testing has advanced significantly since the publication of the 2011
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the …

[PDF][PDF] Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects

H Könemann, N Dagres, JL Merino, C Sticherling… - Europace, 2023 - academic.oup.com
Sudden cardiac death and ventricular arrhythmias are a global health issue. Recently, a
new guideline for the management of ventricular arrhythmias and prevention of sudden …

European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders

LR van den Bersselaar, L Heytens… - European journal of …, 2022 - Wiley Online Library
Background and purpose Patients with neuromuscular conditions are at increased risk of
suffering perioperative complications related to anaesthesia. There is currently little specific …

Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5

SG Priori, A Mazzanti, DJ Santiago, D Kukavica… - Journal of the American …, 2021 - jacc.org
In this final of a 5-part Focus Seminar series on precision medicine, we focus on
catecholaminergic polymorphic ventricular tachycardia (CPVT). This focus on CPVT allows …

Treatment updates for neuromuscular channelopathies

N Jitpimolmard, E Matthews, D Fialho - Current treatment options in …, 2020 - Springer
Purpose of review This article aims to review the current and upcoming treatment options of
primary muscle channelopathies including the non-dystrophic myotonias and periodic …

Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome

AI Moreno-Manuel, LK Gutiérrez… - Cardiovascular …, 2023 - academic.oup.com
Andersen-Tawil syndrome (ATS) is a rare inheritable disease associated with loss-of-
function mutations in KCNJ2, the gene coding the strong inward rectifier potassium channel …

Outcomes of patients with catecholaminergic polymorphic ventricular tachycardia treated with β-blockers

A Mazzanti, D Kukavica, A Trancuccio… - JAMA …, 2022 - jamanetwork.com
Importance Patients with catecholaminergic polymorphic ventricular tachycardia (CPVT)
may experience life-threatening arrhythmic events (LTAEs) despite β-blocker treatment …

Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death

MJ Specterman, ER Behr - Heart, 2023 - heart.bmj.com
There have been remarkable advances in our knowledge of the underlying heritability of
cardiac arrhythmias. Long QT syndrome, Brugada syndrome, catecholaminergic …

Clinical genetics of inherited arrhythmogenic disease in the pediatric population

E Martínez-Barrios, S Cesar, J Cruzalegui… - Biomedicines, 2022 - mdpi.com
Sudden death is a rare event in the pediatric population but with a social shock due to its
presentation as the first symptom in previously healthy children. Comprehensive autopsy in …